Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 12;13(6):1370.
doi: 10.3390/life13061370.

Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle

Affiliations
Review

Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle

Alexandru Florinel Oancea et al. Life (Basel). .

Abstract

Atrial fibrillation, the most frequent arrhythmia in clinical practice and chronic coronary syndrome, is one of the forms of coronary ischemia to have a strong dual relationship. Atrial fibrillation may accelerate atherosclerosis and may increase oxygen consumption in the myocardium, creating a mismatch between supply and demand, thus promoting the development or worsening of coronary ischemia. Chronic coronary syndrome alters the structure and function of gap junction proteins, affecting the conduction of action potential and leading to ischemic necrosis of cardiomyocytes and their replacement with fibrous tissue, in this way sustaining the focal ectopic activity in atrial myocardium. They have many risk factors in common, such as hypertension, obesity, type 2 diabetes mellitus, and dyslipidemia. It is vital for the prognosis of patients to break this vicious circle by controlling risk factors, drug therapies, of which antithrombotic therapy may sometimes be challenging in terms of prothrombotic and bleeding risk, and interventional therapies (revascularization and catheter ablation).

Keywords: atrial fibrillation; chronic coronary syndrome; coronary artery disease; coronary ischemia; triple antithrombotic therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The trigger and substrate in atrial fibrillation pathogenesis.
Figure 2
Figure 2
The evolution of atherosclerotic plaque.
Figure 3
Figure 3
The 11 steps to assess the SYNTAX score.
Figure 4
Figure 4
The vicious circle between atrial fibrillation and chronic coronary syndrome.

References

    1. Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C., Prescott E., Storey R.F., Deaton C., Cuisset T., et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020;41:407–477. doi: 10.1093/eurheartj/ehz425. - DOI - PubMed
    1. Lévy S., Steinbeck G., Santini L., Nabauer M., Maceda D.P., Kantharia B.K., Saksena S., Cappato R. Management of atrial fibrillation: Two decades of progress—A scientific statement from the European Cardiac Arrhythmia Society. J. Interv. Card. Electrophysiol. 2022;65:287–326. doi: 10.1007/s10840-022-01195-z. - DOI - PubMed
    1. Bocchino P.P., Angelini F., Toso E. Atrial fibrillation and coronary artery disease: A review on the optimal use of oral anticoagulants. Rev. Cardiovasc. Med. 2021;22:635–648. doi: 10.31083/j.rcm2203074. - DOI - PubMed
    1. Miftode R.-S., Costache I.-I., Constantinescu D., Mitu O., Timpau A.-S., Hancianu M., Leca D.-A., Miftode I.-L., Jigoranu R.-A., Oancea A.-F., et al. Syndecan-1: From a Promising Novel Cardiac Biomarker to a Surrogate Early Predictor of Kidney and Liver Injury in Patients with Acute Heart Failure. Life. 2023;13:898. doi: 10.3390/life13040898. - DOI - PMC - PubMed
    1. Hajhosseiny R., Munoz C., Cruz G., Khamis R., Kim W.Y., Prieto C., Botnar R.M. Coronary Magnetic Resonance Angiography in Chronic Coronary Syndromes. Front. Cardiovasc. Med. 2021;8:682964. doi: 10.3389/fcvm.2021.682924. - DOI - PMC - PubMed

LinkOut - more resources